Physician profile
Jeffrey E Lanford
NPI 1619083060
$5,913.97
in general payments reported to CMS, 2019-2025
34 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $497 · 2021: $1,871 · 2022: $1,083 · 2023: $401 · 2024: $438 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,592.27 | 2020-2025 | Supera, Esprit, Armada |
| Penumbra, INC. | $1,460.15 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $1,114.10 | 2019 | |
| Medtronic, INC. | $367.74 | 2021-2024 | Hawkone, Endurant Iis, Corevalve Evolut R |
| Inari Medical, INC. | $261.90 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $173.79 | 2019-2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Shockwave Medical, INC | $98.50 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $91.79 | 2020-2025 | Eluvia |
| Smith+Nephew, INC. | $78.70 | 2019-2023 | Pico 14, Renasys Go V2 Home |
| Cook Medical LLC | $60.72 | 2024 | Zilver Ptx |
| Janssen Pharmaceuticals, INC | $60.02 | 2021-2023 | Xarelto |
| Heron Therapeutics, INC. | $54.63 | 2022 | |
| Lemaitre Vascular, INC. | $52.49 | 2019 | |
| Cardiovascular Systems INC. | $44.75 | 2019 | |
| Integra Lifesciences Corporation | $35.66 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $35.25 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $29.46 | 2024 | Keytruda |
| Melinta Therapeutics, LLC | $27.67 | 2019 | |
| Misonix INC | $27.14 | 2020 | |
| Abiomed | $26.54 | 2022 | |
| Veryan Medical Incorporated | $20.96 | 2022 | |
| Osiris Therapeutics INC. | $20.66 | 2019 | |
| Merit Medical Systems INC | $17.88 | 2024 | Savi Scout |
| Karl Storz Endoscopy-America | $17.50 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.84 | 2024 | Exparel |
| Polynovo North America LLC | $16.69 | 2023 | |
| Convatec INC. | $16.18 | 2021 | |
| Avanos Medical | $14.98 | 2022 | |
| Kci USA, INC. | $14.55 | 2022 | |
| Chiesi USA, INC. | $14.37 | 2019 | |
| Baudax Bio INC. | $14.15 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.93 | 2019 | |
| Avinger INC. | $11.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lanford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.